Pigment epithelium-derived factor in ulcerative colitis: Possible relationship with disease activity
- 1 April 2007
- journal article
- Published by Elsevier in Regulatory Peptides
- Vol. 140 (1-2) , 1-4
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Growth factors in inflammatory bowel diseaseInflammatory Bowel Diseases, 2007
- PEDF: a potential molecular therapeutic target with multiple anti-cancer activitiesTrends in Molecular Medicine, 2006
- Pigment epithelium-derived factor: a multimodal tumor inhibitorMolecular Cancer Therapeutics, 2006
- Elevated Serum Levels of Pigment Epithelium-Derived Factor in the Metabolic SyndromeThe Journal of Clinical Endocrinology & Metabolism, 2006
- Angiogenesis as a Novel Component of Inflammatory Bowel Disease PathogenesisGastroenterology, 2006
- Pigment epithelium‐derived factor (PEDF) is an endogenous antiinflammatory factorThe FASEB Journal, 2005
- The neuroprotective and angiogenesis inhibitory serpin, PEDF: new insights into phylogeny, function, and signalingFrontiers in Bioscience-Landmark, 2005
- Retinoic acid and dexamethasone regulate the expression of PEDF in retinal and endothelial cellsExperimental Eye Research, 2004
- Overexpression of Pigment Epithelium-Derived Factor Decreases Angiogenesis and Inhibits the Growth of Human Malignant Melanoma Cells in VivoThe American Journal of Pathology, 2004
- Pigment Epithelium-Derived Factor: A Potent Inhibitor of AngiogenesisScience, 1999